Twist Bioscience (TWST) Net Income towards Common Stockholders (2018 - 2025)
Historic Net Income towards Common Stockholders for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$30.6 million.
- Twist Bioscience's Net Income towards Common Stockholders rose 330.09% to -$30.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$76.6 million, marking a year-over-year increase of 6116.66%. This contributed to the annual value of -$77.7 million for FY2025, which is 6279.57% up from last year.
- Per Twist Bioscience's latest filing, its Net Income towards Common Stockholders stood at -$30.6 million for Q4 2025, which was up 330.09% from -$27.1 million recorded in Q3 2025.
- Twist Bioscience's Net Income towards Common Stockholders' 5-year high stood at $20.4 million during Q2 2025, with a 5-year trough of -$85.6 million in Q2 2024.
- In the last 5 years, Twist Bioscience's Net Income towards Common Stockholders had a median value of -$42.4 million in 2022 and averaged -$42.9 million.
- In the last 5 years, Twist Bioscience's Net Income towards Common Stockholders tumbled by 6946.91% in 2021 and then surged by 12381.51% in 2025.
- Over the past 5 years, Twist Bioscience's Net Income towards Common Stockholders (Quarter) stood at -$45.6 million in 2021, then grew by 8.21% to -$41.8 million in 2022, then dropped by 2.83% to -$43.0 million in 2023, then grew by 26.53% to -$31.6 million in 2024, then increased by 3.3% to -$30.6 million in 2025.
- Its Net Income towards Common Stockholders was -$30.6 million in Q4 2025, compared to -$27.1 million in Q3 2025 and $20.4 million in Q2 2025.